International ME Conference Week Speakers A hallmark of the BRMEC colloquia, since their inception in 2011, has increasingly been to take an approach of bringing together experts from various fields and countries, and introducing fresh perspectives to ME research. This aids in stimulating new ideas to accelerate progress and new knowledge and awareness to be raised amongst researchers. By consistently introducing varied expertise to the field, these events have become a catalyst for innovative thinking in ME research, with the ultimate goal of improving understanding and treatment of this debilitating condition. Colloquium and Conference Chair Simon Carding (Quadram Institute, UK) Research Leader, Quadram Institute Bioscience, Norwich Research Park, UK Simon Carding is Professor of Mucosal Immunology at Norwich Medical School, University of East Anglia, and Research Leader at the Quadram Institute Bioscience, Norwich Research Park. He is internationally recognised for his expertise in mucosal immunology and the gut microbiome, focusing on how gut microbes-including bacteria and viruses-interact with the immune system to influene health and disease. He leads projects investigating the role of the intestinal microbiome and virome in ME, aiming to identify microbial and viral signatures linked to disease onset or progression. His team is conducting comprehensive analyses of the gut virome in ME, including patients in phase 2 clinical trials, to clarify the impact of microbial dysbiosis on the condition and the gut–microbiome–brain axis, with relevance to mental health and neurodegenerative diseases. Professor Carding has been a consistent contributor to Invest in ME Research conferences since 2011, delivering expert talks on gut biology, immunology, and ME. He is a member of the Biomarkers and Immune Working Groups of the ME/CFS Common Data Element Project, reflecting his active role in shaping ME biomedical research. His leadership at the Quadram Institute and collaborations with other institutions highlight his commitment to multidisciplinary research bridging immunology, microbiology, and clinical science to improve understanding and treatment of ME. Invest in ME Research Page 13 of 43
15 Publizr Home